UA60197A - Способ прогнозирования течения вич-инфекции у детей - Google Patents
Способ прогнозирования течения вич-инфекции у детей Download PDFInfo
- Publication number
- UA60197A UA60197A UA2003021783A UA200321783A UA60197A UA 60197 A UA60197 A UA 60197A UA 2003021783 A UA2003021783 A UA 2003021783A UA 200321783 A UA200321783 A UA 200321783A UA 60197 A UA60197 A UA 60197A
- Authority
- UA
- Ukraine
- Prior art keywords
- risk
- coefficient
- optical density
- blood serum
- development
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 5
- 230000003287 optical effect Effects 0.000 claims abstract description 22
- 210000002966 serum Anatomy 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 16
- 201000010099 disease Diseases 0.000 claims abstract description 13
- 210000004700 fetal blood Anatomy 0.000 claims abstract description 8
- 208000029462 Immunodeficiency disease Diseases 0.000 claims description 21
- 230000003612 virological effect Effects 0.000 claims description 21
- 206010061598 Immunodeficiency Diseases 0.000 claims description 20
- 230000007813 immunodeficiency Effects 0.000 claims description 20
- 238000011161 development Methods 0.000 claims description 15
- 208000031886 HIV Infections Diseases 0.000 claims description 5
- 208000037357 HIV infectious disease Diseases 0.000 claims description 4
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 14
- 230000018109 developmental process Effects 0.000 description 10
- 230000035935 pregnancy Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000021846 Limb body wall complex Diseases 0.000 description 1
- 101100187130 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nim-1 gene Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Предлагаемый способ прогнозирования течения ВИЧ-инфекции у детей заключается в том, что определяют оптическую плотность сыворотки крови и коэффициент вероятности развития вирусного иммунодефицита человека. Риск развития заболевания оценивается как незначительный при значении указанного коэффициента вероятности менее 30 % и как значительный при значении коэффициента не менее 30 %. Для расчета коэффициента K вероятности развития вирусного иммунодефицита используется следующая формула: K = [(OD1/OD2) x 100] - 100 %, где OD1 - оптическая плотность сыворотки пуповинной крови в условных единицах, OD2 - оптическая плотность сыворотки обычной крови в условных единицах.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2003021783A UA60197A (ru) | 2003-02-28 | 2003-02-28 | Способ прогнозирования течения вич-инфекции у детей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2003021783A UA60197A (ru) | 2003-02-28 | 2003-02-28 | Способ прогнозирования течения вич-инфекции у детей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA60197A true UA60197A (ru) | 2003-09-15 |
Family
ID=74220882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003021783A UA60197A (ru) | 2003-02-28 | 2003-02-28 | Способ прогнозирования течения вич-инфекции у детей |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA60197A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2670652C2 (ru) * | 2017-03-30 | 2018-10-24 | Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) | Способ оценки тяжести состояния больного при ВИЧ-инфекции |
-
2003
- 2003-02-28 UA UA2003021783A patent/UA60197A/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2670652C2 (ru) * | 2017-03-30 | 2018-10-24 | Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) | Способ оценки тяжести состояния больного при ВИЧ-инфекции |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nayak et al. | VDRL test and its interpretation | |
| Ahlstedt | Understanding the usefulness of specific IgE blood tests in allergy. | |
| Thomas et al. | Urinary and plasma fluoride levels in pregnant women from Mexico City | |
| CN105229470B (zh) | 用于治疗和诊断系统性红斑狼疮的方法 | |
| Boucoiran et al. | Guideline no. 420: cytomegalovirus infection in pregnancy | |
| Tanimura et al. | Potential biomarkers for predicting congenital cytomegalovirus infection | |
| Abdullahi Nasir et al. | Clinical significance of IgG avidity testing and other considerations in the diagnosis of congenital cytomegalovirus infection: a review update | |
| JPH11511255A (ja) | 診断測定法におけるリウマチ因子干渉の除去方法 | |
| Pour Abolghasem et al. | IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in Early | |
| Peterson et al. | The relationship of maternal and child HIV infection to security of attachment among Ugandan infants | |
| Ferrés et al. | Mother-to-child transmission of Andes virus through breast milk, Chile | |
| Commenges et al. | Estimating the incubation period of paediatric AIDS in Rwanda | |
| US20110177531A1 (en) | Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus Erythematosus | |
| Brown et al. | Screening for intestinal helminth infestation in a semi-urban cohort of HIV-infected people in Uganda: a combination of techniques may enhance diagnostic yield in the absence of multiple stool samples | |
| UA60197A (ru) | Способ прогнозирования течения вич-инфекции у детей | |
| Ifeanyichukwu et al. | Effect of HIV Infection on some haematological parameters and immunoglobulin levels in HIV patients in Benin city, Southern Nigeria | |
| Fondoh et al. | Haematological reference intervals for healthy adults in Bamenda, Cameroon | |
| Izquierdo et al. | Optimizing congenital cytomegalovirus detection by pool testing in saliva by a rapid molecular test | |
| Murhima’Alika et al. | Bahati Lufungulo Y, Mwene-Batu Lyabayungu P, Garhalangwa Mayeri D, Gaylord AN, et al.(2022) Nutritional and health status of a cohort of school-age children born to mothers treated for severe acute malnutrition in their childhood in The Democratic Republic of Congo | |
| Sadeep et al. | Syphilis in pregnancy | |
| Kamioka et al. | Probability curves for predicting symptom severity during an oral food challenge with wheat | |
| ANDIMAN et al. | Predictive value of the human immunodeficiency virus 1 antigen test in children born to infected mothers | |
| Murhima’Alika et al. | Nutritional and health status of a cohort of school-age children born to mothers treated for severe acute malnutrition in their childhood in The Democratic Republic of Congo | |
| RU2750353C1 (ru) | Способ прогнозирования пищевой аллергии к белку коровьего молока у детей | |
| Amadi et al. | Usefulness of Chlamydia serology in prediction of tubal factor infertility among infertile patients at Federal Medical Centre, Bida, North Central Nigeria |